Renewmedicalwa
- Ozone Therapy
- IV Therapy
- Transcranial Magnetic Stimulation (TMS)
- Peptide Therapy
- Hormone Replacement Therapy (HRT)
Edmonds, WA
Edmonds sits on the Puget Sound north of Seattle and hosts a small IV therapy scene shaped by a wealthy waterfront residential base, ferry commuter traffic to Kingston, and overflow volume from Shoreline and Lynnwood. Clinics concentrate in downtown Edmonds, near the ferry terminal, and along Highway 99. Swedish Edmonds, Providence Regional Medical Center Everett, and the broader Providence Swedish network anchor the clinical ecosystem supplying many medical directors. Washington is a full-practice state for nurse practitioners and separately licenses naturopathic physicians with IV therapy scope, so Edmonds IV clinics split between NP-led, ND-led, and physician-directed models. The Pacific Northwest winter drives steady immune drip demand, affluent waterfront residents drive NAD+ and longevity volume, and the Interurban Trail running and cycling community supports athletic recovery bookings. Mobile IV services reach Shoreline, Lynnwood, and Woodinville.
Regulatory context
FDA regulates the compounded ingredients used in IV therapy and the facilities that prepare them. Patient-specific compounded IVs fall under FDCA Section 503A, while bulk preparations for office use fall under Section 503B (outsourcing facilities). USP Chapter 797 governs sterile compounding standards. FDA has issued warnings about injectable glutathione marketed for skin lightening (2017) and has not approved NAD IV for any specific indication. Vitamin and mineral IV mixtures such as the Myers cocktail are compounded preparations and are not FDA-approved drug products.
The Washington medical and nursing boards have addressed unlicensed practice in medical spa and IV lounge settings. Common enforcement themes include IV therapy administered without a valid physician order, stale or missing standing orders, absence of a designated medical director, and unlicensed personnel performing venipuncture. Boards have reiterated that a prescribing physician or APRN must establish a bona fide patient relationship before any IV protocol is initiated, and that standing orders must be specific, dated, and periodically reviewed.